Cleared Traditional

K913061 - FIBRINOGEN DETERMINATION KIT

K913061 is an FDA 510(k) clearance for FIBRINOGEN DETERMINATION KIT, manufactured by Sigma Diagnostics, Inc.. The device is a Class 2 Hematology device with product code GIS cleared through the Traditional 510(k) pathway after a 91-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1991
Decision
91d
Days
Class 2
Risk

K913061 is an FDA 510(k) clearance for the FIBRINOGEN DETERMINATION KIT. Classified as Test, Fibrinogen (product code GIS), Class II - Special Controls.

Submitted by Sigma Diagnostics, Inc. (St. Louis, US). The FDA issued a Cleared decision on October 9, 1991 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7340 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sigma Diagnostics, Inc. devices

FDA 510(k) Submission Details - K913061

510(k) Number K913061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 1991
Decision Date October 09, 1991
Days to Decision 91 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 113d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GIS Device Classification - Class 2, Special Controls

Product Code GIS Test, Fibrinogen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GIS Test, Fibrinogen

All 9
Devices cleared under the same product code (GIS) and FDA review panel - the closest regulatory comparables to K913061.
QUANTITATIVE FIBRINOGEN ASSAY
K963902 · Ortho Diagnostic Systems, Inc. · Nov 1996
BIOMERIEUX HEMOLAB FIBRINOMAT
K925494 · Biomerieux Vitek, Inc. · May 1993
IL TEST PT FIBRINOGEN HS
K923921 · Instrumentation Laboratory CO · Oct 1992
FIBRINOGENTEST-O
K881685 · Diatech, Inc. · Aug 1988
KINETIC FIBRINOGEN ASSAY
K881150 · Bio/Data Corp. · Mar 1988
ASSAY KIT, THROMBO-SCREEN
K781880 · Pacific Hemostasis · Dec 1978